CHQSXP(SZ:000565) Xin Lang Cai Jing·2025-10-29 01:44Core Insights - The company reported a total revenue of 287 million yuan for Q3 2025, an increase of 18.96 million yuan compared to the same period last year, representing a year-on-year growth of 7.07% [1] - The net profit attributable to shareholders reached 16.49 million yuan, up by 1.46 million yuan from the same period last year, marking a year-on-year increase of 9.69% and achieving two consecutive years of growth [1] - The company experienced a net cash outflow from operating activities of 37.75 million yuan [1] Financial Ratios - The latest debt-to-asset ratio stands at 22.53%, ranking 39th among disclosed peers [3] - The gross profit margin is reported at 25.64%, ranking 47th among disclosed peers, with a quarter-on-quarter increase of 0.19 percentage points and a year-on-year increase of 1.82 percentage points [3] - The return on equity (ROE) is 1.32%, which is an increase of 0.12 percentage points compared to the same period last year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is 0.04 yuan, an increase of 0.01 yuan from the same period last year, achieving two consecutive years of growth and a year-on-year increase of 33.33% [3] - The total asset turnover ratio is 0.18 times, remaining stable compared to the same period last year, with a year-on-year increase of 2.09% [3] - The inventory turnover ratio is 2.57 times, an increase of 0.08 times from the same period last year, representing a year-on-year growth of 3.10% [3] Shareholder Structure - The number of shareholders is 53,500, with the top ten shareholders holding a total of 184 million shares, accounting for 42.43% of the total share capital [3] - The largest shareholder is Chongqing Life Science and New Materials Industry Group Co., Ltd., holding 40.55% of the shares [3]